Skip to content

PLOS is a non-profit organization on a mission to drive open science forward with measurable, meaningful change in research publishing, policy, and practice.

Building on a strong legacy of pioneering innovation, PLOS continues to be a catalyst, reimagining models to meet open science principles, removing barriers and promoting inclusion in knowledge creation and sharing, and publishing research outputs that enable everyone to learn from, reuse and build upon scientific knowledge.

We believe in a better future where science is open to all, for all.

Medicine & Health

Are Drug Companies Living Up to Their Human Rights Responsibilities? Three Viewpoints

Curated Collections

In September 2010, the PLOS Medicine Debate asked whether drug companies are living up to their human rights responsibilities. Sofia Gruskin and Zyde Raadfrom the Harvard School of Public Health say more assessment is needed of such responsibilities; Geralyn Ritter, Vice President of Global Public Policy and Corporate Responsibility at Merck & Co. argues that multiple stakeholders could do more to help States deliver the right to health; and Paul Hunt and Rajat Khosla introduce Mr. Hunt's work as the UN Special Rapporteur on the right to health (2002-2008), regarding the human rights responsibilities of pharmaceutical companies and access to medicines.

Image Credit: Brooks Elliott

Editorial
The PLOS Medicine Debates
PLOS Collections Blog - Research Analysis & Science Policy

Loading...

PLOS Collections Blog - Medicine & Health Sciences

Loading...

Back to top